Two pricing problems operators face on The Rx Spot
Operators launching a telehealth brand on The Rx Spot face two distinct pricing decisions. First, what patient retail price to set — and here, The Rx Spot's tiered and volume-based pricing tools give real flexibility: operators configure it from the Marketplace Dashboard, set multi-tier structures, and push updates across the storefront instantly. Second, what drug acquisition actually costs. Fulfillment runs through 503A and 503B compounding partners behind the platform, and per-unit acquisition cost is not on a public rate card — operators work this out through the demo and onboarding process before configuring storefront pricing.
The gap between these two decisions is the operator's margin — and tracking it is what the platform earnings reconciliation dashboard is built for. Operators can monitor orders shipped, pending orders, and earnings to see how patient revenue maps to fulfillment cost over time. What the tools do not replace is confirming drug acquisition cost before you set patient prices, so you know the spread you are building on.